Dose Justification for Asciminib in Patients with Philadelphia Chromosome-Positive Chronic Myeloid Leukemia with and Without the T315I Mutation. [PDF]
Combes FP+7 more
europepmc +1 more source
Reduced-dose chemotherapy followed by blinatumomab for newly diagnosed philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemia: a propensity-matched comparison with hyper-CVAD. [PDF]
Lu J+21 more
europepmc +1 more source
A Case of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in a 26-Year-Old Pregnant Woman. [PDF]
Shaykh N+6 more
europepmc +1 more source
Ponalfil trial for adults with Philadelphia chromosome-positive acute lymphoblastic leukemia: Long-term results. [PDF]
Ribera JM+16 more
europepmc +1 more source
Comparison of blinatumomab and chimeric antigen receptor T cells pre-haploidentical hematopoietic stem cell transplantation for pediatric Philadelphia chromosome negative B-cell acute lymphoblastic leukemia. [PDF]
Hu G+5 more
europepmc +1 more source
Olverembatinib combined with inotuzumab ozogamicin in relapsed refractory Philadelphia chromosome-positive acute lymphoblastic leukemia: A case report. [PDF]
Liu T, Wang C, Fu Y, Yang YP, Tan YH.
europepmc +1 more source